Growth retardation, reduced invasiveness, and impaired colistin-mediated cell death associated with colistin resistance development in Acinetobacter baumannii

scientific article

Growth retardation, reduced invasiveness, and impaired colistin-mediated cell death associated with colistin resistance development in Acinetobacter baumannii is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1128/AAC.01439-13
P932PMC publication ID3910856
P698PubMed publication ID24247145

P50authorPascal CosetteQ48604695
Emmanuelle DéQ57658572
Julie HardouinQ79177677
P2093author name stringAthanassios Tsakris
Demosthenes Makris
Spyros Pournaras
Aggeliki Poulou
Ioulia Kristo
Konstantina Dafopoulou
Yassine Nait Chabane
P2860cites workA common mechanism of cellular death induced by bactericidal antibioticsQ28246128
CspR, a cold shock RNA-binding protein involved in the long-term survival and the virulence of Enterococcus faecalisQ28485694
Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typingQ29614699
The population structure of Acinetobacter baumannii: expanding multiresistant clones from an ancestral susceptible genetic poolQ33552298
Phosphoethanolamine modification of lipid A in colistin-resistant variants of Acinetobacter baumannii mediated by the pmrAB two-component regulatory system.Q33901939
Growth of Acinetobacter baumannii in pellicle enhanced the expression of potential virulence factorsQ34064343
Novel acquired metallo-beta-lactamase gene, bla(SIM-1), in a class 1 integron from Acinetobacter baumannii clinical isolates from KoreaQ34123619
Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide productionQ34309451
Extracellular proteome of a highly invasive multidrug-resistant clinical strain of Acinetobacter baumanniiQ34411048
Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosaQ34555131
Impaired virulence and in vivo fitness of colistin-resistant Acinetobacter baumannii.Q34764355
Rapid killing of Acinetobacter baumannii by polymyxins is mediated by a hydroxyl radical death pathwayQ36364121
The epidemiology and control of Acinetobacter baumannii in health care facilitiesQ36382140
Colistin resistance in a clinical Acinetobacter baumannii strain appearing after colistin treatment: effect on virulence and bacterial fitness.Q37124050
Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component systemQ37333088
Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategiesQ37996299
Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages.Q38057841
A review on recent developments in mass spectrometry instrumentation and quantitative tools advancing bacterial proteomicsQ38102548
Prevalence of metallo-beta-lactamase among Pseudomonas aeruginosa and Acinetobacter baumannii in a Korean university hospital and comparison of screening methods for detecting metallo-beta-lactamaseQ42168402
Colistin MIC variability by method for contemporary clinical isolates of multidrug-resistant Gram-negative bacilliQ42190018
Heteroresistance to meropenem in carbapenem-susceptible Acinetobacter baumanniiQ42689045
Global spread of carbapenem-resistant Acinetobacter baumanniiQ43227337
Nosocomial outbreak of infection with pan-drug-resistant Acinetobacter baumannii in a tertiary care university hospitalQ43756833
Selection of topoisomerase mutations and overexpression of adeB mRNA transcripts during an outbreak of Acinetobacter baumanniiQ45050449
Outbreak of multiple clones of imipenem-resistant Acinetobacter baumannii isolates expressing OXA-58 carbapenemase in an intensive care unitQ46907740
The cost of resistance to colistin in Acinetobacter baumannii: a proteomic perspective.Q51791235
Correlation between overexpression and amino acid substitution of the PmrAB locus and colistin resistance in Acinetobacter baumannii.Q54377706
Acinetobacter baumannii Resistant to Colistin With Impaired Virulence: A Case Report From FranceQ56572609
Peptide antibioticsQ73073957
Attenuated virulence of a slow-growing pandrug-resistant Acinetobacter baumannii is associated with decreased expression of genes encoding the porins CarO and OprD-likeQ84974548
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectAcinetobacter baumanniiQ3241189
cell deathQ2383867
P304page(s)828-832
P577publication date2013-11-18
P1433published inAntimicrobial Agents and ChemotherapyQ578004
P1476titleGrowth retardation, reduced invasiveness, and impaired colistin-mediated cell death associated with colistin resistance development in Acinetobacter baumannii
P478volume58

Reverse relations

cites work (P2860)
Q55404021Acinetobacter baumannii: Epidemiological and Beta-Lactamase Data From Two Tertiary Academic Hospitals in Tshwane, South Africa.
Q43350495Altered susceptibility to the bactericidal effect of photocatalytic oxidation by TiO2 is related to colistin resistance development in Acinetobacter baumannii
Q55135895Association of virulence gene expression with colistin-resistance in Acinetobacter baumannii: analysis of genotype, antimicrobial susceptibility, and biofilm formation.
Q53703223Chromosomally encoded and plasmid-mediated polymyxins resistance in Acinetobacter baumannii: a huge public health threat.
Q64124128Colistin Heteroresistance and Involvement of the PmrAB Regulatory System in Acinetobacter baumannii
Q39514967Colistin Resistance Caused by Inactivation of the MgrB Regulator Is Not Associated with Decreased Virulence of Sequence Type 258 KPC Carbapenemase-Producing Klebsiella pneumoniae
Q60919466Colistin Resistant : Genomic and Transcriptomic Traits Acquired Under Colistin Therapy
Q41220559Colistin and Fusidic Acid, a Novel Potent Synergistic Combination for Treatment of Multidrug-Resistant Acinetobacter baumannii Infections
Q28076261Colistin in Pig Production: Chemistry, Mechanism of Antibacterial Action, Microbial Resistance Emergence, and One Health Perspectives
Q36644871Colistin-Resistant Acinetobacter baumannii Clinical Strains with Deficient Biofilm Formation
Q57656298Emergence of High-Level Colistin Resistance in an Acinetobacter baumannii Clinical Isolate Mediated by Inactivation of the Global Regulator H-NS
Q40176183Evaluation of two automated systems for colistin susceptibility testing of carbapenem-resistant Acinetobacter baumannii clinical isolates
Q87991381Fitness cost of mcr-1-mediated polymyxin resistance in Klebsiella pneumoniae
Q50352226Growth Rate and Biofilm Formation Ability of Clinical and Laboratory-Evolved Colistin-Resistant Strains of Acinetobacter baumannii
Q35843094High prevalence of oxacillinases in clinical multidrug-resistant Acinetobacter baumannii isolates from the Tshwane region, South Africa - an update.
Q35202480Impact of Acinetobacter baumannii superoxide dismutase on motility, virulence, oxidative stress resistance and susceptibility to antibiotics
Q47136007Interplay between Colistin Resistance, Virulence and Fitness in Acinetobacter baumannii
Q38287949Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria
Q53696497Phenotypic Changes Associated with Colistin Resistance due to Lipopolysaccharide Loss in Acinetobacter baumannii.
Q38922536Polymyxin: Alternative Mechanisms of Action and Resistance.
Q34552966Polymyxins: Antibacterial Activity, Susceptibility Testing, and Resistance Mechanisms Encoded by Plasmids or Chromosomes
Q36438931Preservation of Acquired Colistin Resistance in Gram-Negative Bacteria
Q26749601Proteomics As a Tool for Studying Bacterial Virulence and Antimicrobial Resistance
Q39190865Recent advances and perspectives in the design and development of polymyxins.
Q41998459Retention of virulence following adaptation to colistin in Acinetobacter baumannii reflects the mechanism of resistance.
Q40690118Synergy between Colistin and the Signal Peptidase Inhibitor MD3 Is Dependent on the Mechanism of Colistin Resistance in Acinetobacter baumannii
Q35432662The transcriptomic response of Acinetobacter baumannii to colistin and doripenem alone and in combination in an in vitro pharmacokinetics/pharmacodynamics model
Q40065990Transcriptional and mutational profiling of an aminoglycoside resistant Pseudomonas aeruginosa small colony variant.

Search more.